A Double-Blind, Randomised, Single Centre, Placebo-Controlled Phase II Study to Evaluate the Safety and Efficacy of a Single Subcutaneous Implant of EPT 1647 in Patients Suffering from Recurrent Polymorphous Light Eruption

This study is testing whether a small implant injected under the skin can reduce the number and severity of flare-ups of polymorphous light eruption (PMLE). PMLE is a condition where the skin becomes very sensitive to sunlight, causing a rash on areas exposed to the sun. The implant slowly releases a substance that may help increase the skin's tolerance to sunlight. Researchers want to find out if this treatment is safe and effective. You may be eligible if: - You have a history of polymorphous light eruption (PMLE), a sun-sensitive skin condition that causes a rash You may NOT be eligible if: - You have a history of skin cancer Talk to your doctor about whether this trial might be right for you.